Australasian Journal of Dermatology provides the latest peer-reviewed, original research articles, reviews and case reports dealing with all aspects of clinical practice and research in dermatology.
Australian Teledermatology experience during COVID-19
Zhi Mei Low, Laura Scardamaglia, Vanessa Morgan, Johannes S Kern. AJD (2021). Research letter.
For almost 3 months of 2020, Victoria was in lockdown due to the coronavirus pandemic. This led to dermatologists gaining first-hand experience in teledermatology as surgical dermatology was reduced to 1 session of Category 1 and 2 cases.
Analysis of dermatology telehealth at Royal Melbourne Hospital (RMH) during the 2.5 month period was undertaken and compared to dermatologists’ experiences Australia-wide.
At RMH, 267 telehealth consultations and 124 face-to-face consultations were conducted. Majority of dermatologists found telehealth consultations to be inadequate or inferior to face-to-face consultations, with only 27% finding the encounter to be equal to face-to-face consultations.
To put this local experience into broader context, 559 Australian dermatologists were invited to participate in an online survey on their telehealth experience. Of those, 127 dermatologists completed the survey, with just over half utilising telehealth consultation prior to 2020.
Nearly 80% of dermatologists found skin checks via telehealth inappropriate, compared to RMH where all skin check telehealth consultations were deemed inappropriate or inferior. More than two-thirds of dermatologists found telehealth to be an appropriate method in providing care for patients on biologic therapy, and this was similar at RMH (76% were superior or equal to face-to-face consultations).
While teledermatology appears to be most suited for the ongoing care of patients on biologic therapy, other approaches should be considered first for skin checks.
About the Journal
The Australasian Journal of Dermatology is the official journal of the Australasian College of Dermatologists and the New Zealand Dermatological Society. Editorially independent and peer-reviewed, the journal showcases the latest in dermatology research and innovation.
With four issues a year and special editions, the journal covers clinical presentations, medical and physical therapies and investigations, including dermatopathology, mycology, dermoscopy, surgery and contact dermatitis.
2020 Journal metrics
Accessing the Journal
ACD members have complimentary access to the AJD. Members can access the journal by logging into the Members only section of College’s website and selecting ‘My Online Journals’.
Professor Kiarash Khosrotehrani
Institute of Molecular Bioscience, The University of Queensland Diamantina Institute, Brisbane, Australia.
Associate Professor Helmut Schaider
Dermatology Research Centre, School of Medicine, University of Queensland, Brisbane, Australia.
Professor Khosrotehrani is a clinician-scientist, practicing dermatologist with a focus on delivering state of the art concept and technologies to real-world clinical problems.
A Fellow of the Australasian College of Dermatologists (ACD), he leads the Experimental Dermatology Group at the University of Queensland Diamantina Institute in Brisbane, Australia; is deputy director of the Australian Skin and Skin Cancer Research Centre in Brisbane and practises at the Princess Alexandra Hospital and the Skin and Cancer Foundation’s Queensland Institute of Dermatology.
Passionate about the development of academic medicine and future academic clinicians, he is chair of ACD’s Academic Research Committee, President of the Australasian Society for Dermatology Research and a board member of the International Society for Investigative Dermatology.
He obtained his MD in Paris, France specialising in Dermatology and is a former graduate of the Ecole Normale Supérieure and the Institut Pasteur of Paris (Université Paris VI, Pierre et Marie Curie) obtaining a PhD in Physiology and Physiopathology. He completed his post-doctoral training in stem cell biology and clinical genetics at Tufts-New England Medical Centre in Boston, USA.
Acknowledged by the National Health and Medical Research Council (NHMRC) of Australia through an achievement award (2011) and an NHMRC excellence award (2016), his research is fundamentally based on regenerative medicine concepts applied at basic, translational and clinical levels to melanoma, keratinocyte cancers and skin wounds and takes a multidisciplinary approach. This unique expertise and leadership in research is witnessed by a record of highly cited articles (over 3700 citations, H index 33).
Associate Professor Schaider is an academic dermatologist recognised as a clinical researcher in skin cancer focusing on melanoma biology and early detection of melanoma.
He is a Fellow of the Australasian College of Dermatologists, Treasurer of the Australasian Society of Dermatology Research and is practising at the Sunshine Coast University Hospital and the Princess Alexandra Hospital, Brisbane.
He obtained his medical degree at the Medical University of Graz, Austria, and received training as a postdoctoral researcher in pharmacology at the German Cancer Research Centre, Heidelberg, Germany and melanoma biology at The Wistar Institute, Philadelphia, US.
After relocating to Australia, he set up an independent research group at the Translational Research Institute, Brisbane aiming to identify novel targets tackling cancer drug resistance and improving early detection of melanoma. His group recently identified a chronic stress induced drug tolerant phenotype in cancer and found a novel potential druggable target. Early detection of melanoma is utilizing cutting edge technology like 3D whole body photography to develop surveillance programs for high-risk patients.
|Dr Nikki Adler||Monash University, Melbourne, Australia|
|Dr Keng Chen||Sable Dermatology, Sydney, Australia|
|Dr Peggy Chen||Taranaki District Health Board, New Plymouth, New Zealand|
|Dr Harriet Cheng||Auckland City Hospital, Auckland|
|Dr Karen Cheung||The Skin Hospital, Sydney, Australia|
|Dr Haady Fallah||Concord Repatriation General Hospital, Sydney, Australia|
|Dr Esther Hong||Royal North Shore Hospital of Sydney, Sydney, Australia|
|Dr Joseph Konya||The Skin Hospital, Sydney, Australia|
|Prof Prasad Kumarasinghe||Fiona Stanley Hospital, Perth, Australia|
|A/Prof Christopher McCormack||Peter MacCallum Cancer Centre, Melbourne Australia|
|Dr Anne O’Neill||The Children’s Hospital at Westmead, Sydney Australia|
|Dr David Orchard||Private Suites Royal Children’s Hospital, Melbourne, Australia|
|Dr Yan Pan||Victorian Melanoma Service, Alfred Hospital, VIC, Australia|
|A/Prof Helmut Schaider||Dermatology Research Centre, The University of Queensland Diamantina Institute, Brisbane, Australia|
|A/Prof Stephen Shumack||Royal North Shore Hospital of Sydney, Sydney, Australia|
|Prof Rodney Sinclair||University of Melbourne and Epworth Hospital, Melbourne, Australia|
|Prof H Peter Soyer||Dermatology Research Centre, The University of Queensland Diamantina Institute, Brisbane, Australia|
|Dr Keng-Ee Thai||Royal Australian Army Medical Corps|
|Dr Orli Wargon||Sydney Children’s Hospital, Sydney, Australia|
|Dr Ashfaq Marghoob||Memorial Sloan Kettering Skin Cancer Center, New York, NY, USA|
|Prof John McGrath||St John’s Institute of Dermatology, London, United Kingdom|
|Dr Masaru Tanaka||Tokyo Woman’s Medical University, Medical Center East, Tokyo, Japan|
|Dr Mark Tang||National Skin Centre, Singapore|
|Dr Clark C Otley||Mayo Clinic, Rochester, USA|